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Abstract
Introduction: Surveillance of recent HIV infections in national testing services has the potential to inform primary prevention
programming activities. Focusing on procedures required to accurately determine recent infection, and the potential for recent
infection surveillance to inform prevention efforts, we present the results of three independent but linked pilots of recency
testing.
Methods: To distinguish recently acquired HIV infection from long-standing infection, in 2018 we applied a Recent Infection
Testing Algorithm that combined a laboratory-based Limiting Antigen Avidity Enzyme Immunoassay with clinical information
(viral-load; history of prior HIV diagnosis; antiretroviral therapy-exposure). We explored potential misclassification of test
results and analysed the characteristics of participants with recent infection. We applied the algorithm in antenatal clinics pro-
viding prevention of mother-to-child transmission services in Siaya County, Kenya, outreach sites serving female sex workers
in Zimbabwe, and routine HIV testing and counselling facilities in Nairobi, Kenya. In Nairobi, we also conducted recency testing
among partners of HIV-positive participants.
Results: In Siaya County, 2.3% (10/426) of HIV-positive pregnant women were classified as recent. A risk factor analysis com-
paring women testing recent with those testing HIV-negative found women in their first trimester were significantly more
likely to test recent than those in their second or third trimester. In Zimbabwe, 10.5% (33/313) of female sex workers testing
HIV-positive through the outreach programme were classified recent. A risk factor analysis of women testing recent versus
those testing HIV-negative, found no strong evidence of an association with recent infection. In Nairobi, among 532 HIV-posi-
tive women and men, 8.6% (46) were classified recent. Among partners of participants, almost a quarter of those who tested
HIV-positive were classified as recent (23.8%; 5/21). In all three settings, the inclusion of clinical information helped improve
the positive predictive value of recent infection testing by removing cases that were likely misclassified.
Conclusions: We successfully identified recently acquired infections among persons testing HIV-positive in routine testing set-
tings and highlight the importance of incorporating additional information to accurately classify recent infection. We identified
a number of groups with a significantly higher proportion of recent infection, suggesting recent infection surveillance, when
rolled-out nationally, may help in further targeting primary prevention efforts.
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1 | INTRODUCTION
Knowing where and among whom new HIV infections are
occurring is helpful in estimating HIV incidence and also,
potentially, in guiding prevention programmes and evaluating
their impact [1-7]. Identifying hotspots, at the population-level,
of recently acquired HIV infection could help programmes
identify where and among whom primary prevention efforts
such as pre-exposure prophylaxis (PrEP) and voluntary medical
male circumcision (VMMC) should be intensified. Information
on recently acquired HIV may also inform primary prevention
efforts at the individual level. For example prioritizing partner
notification services among newly diagnosed persons who
have acquired HIV recently may minimize recall bias relating
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to partner information [8], and assist efforts to reach a per-
son’s most recent partners to encourage them to seek testing
and preventative services.
A number of laboratory-based assays have been developed
that can identify recent HIV infections through the testing of
blood specimens [9,10]. These assays utilize specific antibody
markers that evolve in the months following infection. When
interpreted as part of a Recent Infection Testing Algorithm
(RITA) (where laboratory test results are combined with other
information to classify an HIV infection), these assays are able
to distinguish recently acquired infection from long-standing
infection among persons being diagnosed with HIV [6,10].
They have been used in national population-based HIV impact
assessment (PHIA) surveys in 12 high-burden African coun-
tries to estimate national HIV incidence [11-13]. In 2018, the
United States President’s Emergency Plan for AIDS Relief
(PEPFAR) called for recent infection surveillance to be imple-
mented at scale in supported countries [14,15]
We present the results of three independent but linked
pilots of HIV recency testing in routine service-provision set-
tings in Kenya and Zimbabwe.
2 | METHODS
To explore whether RITAs can be applied in routine service
setting in sub-Saharan Africa, and whether the information
generated can be used to inform prevention activities, we
chose a variety of routine service-provision contexts in Kenya
and Zimbabwe to conduct recency testing. These settings
were as follows: antenatal clinics providing prevention of
mother-to-child transmission (PMTCT) services in Siaya
County, Kenya, a national programme for female sex workers
in Zimbabwe, and HIV testing and counselling (HTC) facilities
in Nairobi, Kenya.
2.1 | Data collection and sample processing
Prior to the commencement of our pilots, all study staff
underwent training on good clinical practice, ethics and the
handling of confidential information as per our study proto-
cols. Eligible participants were asked to read and sign a con-
sent form and were probed for their understanding. For
illiterate participants, study staff read the forms out and
sought consent in the presence of an independent witness.
Data were collected between February and November 2018.
In all three pilots, anti-HIV-1-positive specimens were classi-
fied as either recent or long-standing using a RITA that com-
bined a LAg Avidity EIA (a single-well avidity assay that
provides a measure of antibody avidity as normalized optical
density (ODn)) with information on viral-load, history of prior
HIV diagnosis and/or exposure to antiretroviral therapy (ART))
(Figure 1). This RITA gives an indication as to whether or not
a person being diagnosed with HIV is likely to have been
infected within the last four to six months.
The Maxim HIV-1 LAg-Avidity EIA Dried Blood Spot (DBS)
Kit was used in Nairobi on DBS samples, with the Maxim
HIV-1 LAg-Avidity EIA being used in Siaya County and Zim-
babwe on plasma samples. As per manufacturer guidance, LAg
tests with an initial ODn value ≤ 2.0 were retested in tripli-
cate from a fresh dilution of the specimen to confirm the
result, and confirmatory anti-HIV serology was performed on
specimens with an ODn value < 0.4. Viral-load was measured
using the Abbott m2000, Roche Cobas Ampliprep/Cobas Taq-
man or similar automated platform, according to manufactur-
ers’ instructions. Internal quality control checks were run
according to manufacturers’ instructions. Persons with a final
ODn ≤ 1.5 and a viral-load> 1000 copies/ml were classified
as recent infection positive in the absence of ART testing.
As the inclusion of information on ART-exposure could
improve RITA performance through lowering false-recent mis-
classification [4,16], samples assessed as recent in Nairobi
were sent to the Pharmacokinetic Laboratory at the Univer-
sity of Cape Town to test for the presence of ART metabo-
lites in the blood (metabolites, including Lopinavir, Ritonavir,
Nevirapine, Efavirenz, Indinavir, Saquinavir, Zidovudine, Lami-
vudine and Stavudine, were quantified by a robust simultane-
ous liquid chromatography/tandem mass spectrometry
method)[17,18].
In Siaya County, recent samples were linked to a woman’s
antenatal clinic record to explore ART-exposure, and were also
linked to their antenatal clinic and Health and Demographic
Surveillance Site (HDSS) record to explore testing history for
prevalent infection. Evidence of ART-exposure or previous
HIV-positive test would potentially result in a recent infection
being reclassified as long-standing. Table 1 summarizes our
recruitment and testing approach per pilot.
For all three pilots we collected information on participants’
sex, age, marital status and testing facility. In Zimbabwe and
Nairobi, level of education was also collected. In addition,
number of pregnancies and pregnancy trimester was collected
in Siaya County, and employment status, HIV testing history
and pregnancy status was collected in Nairobi.
2.2 | Statistical analysis
We developed a flowchart to show the flow of participants
and sample testing for all three pilots together, starting with
all those presenting for testing, and ending with final classifi-
cation of recent and long-standing HIV infection. We present
Figure 1. Recency testing algorithm (RITA) as applied in the three
pilots.
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the number of people testing recent prior and subsequent to
viral-load testing and ART investigations. In relation to ART-
exposure, we detail each misclassification case.
Using the Siaya county and, separately, the Zimbabwe
data we describe the characteristics of those testing
HIV-positive and classified as recent. To look for risk
factors for recent HIV infection, we applied logistic
regression where women testing HIV-positive and recent
were compared with those testing HIV-negative. In Siaya
County, due to a small number of recent cases, it was
Table 1. Three pilots of HIV recent infection testing in routine service settings
Siaya County, Kenya Nairobi, Kenya Sisters with a Voice, Zimbabwe
Setting
Estimated HIV prevalence of 21% in 2017
[26]. Fertility rate> five children per woman,
and almost all women (94%) access
antenatal care at some point during
pregnancy [27].
Setting
Estimated HIV prevalence of 12% in
population served by participating clinics in
Eastern Nairobi [28].
Setting
Across participating facilities, prevalence of
HIV among FSW is on average 58%
[20,29,30]. HIV incidence rates are poorly
understood, but may be as high as 10% per
year [31].
Collaborative partner
Kenya Medical Research Institute (KEMRI) and
the KEMRI/CDC Siaya HDSS
Collaborative partner
Eastern Deanery AIDS Relief Programme
(EDARP)
Collaborative partner
Centre for Sexual Health and HIV AIDS
Research Zimbabwe (CeSHHAR-Zimbabwe)
Study population
Pregnant women seeking antenatal care in
fourteen medical facilities
Study population
Clients attending any of the fourteen EDARP
HTC facilities
Study population
FSW attending one of six static facilities of the
Sisters with a Voice Programme that
provide a range of services including testing
and referral to government ART services
[31].
Study period
February – November 2018
Study period
March – November 2018
Study period
June – November 2018
Assay
Maxim HIV-1 LAg-Avidity EIA venous blood
Assay
Maxim HIV-1 LAg-Avidity EIA Dried Blood
Spot
Assay
Maxim HIV-1 LAg-Avidity EIA venous blood
Inclusion criteria
• Women aged 13 or older seeking antenatal
care in one of the selected medical facilities
in Siaya County
• Provides informed consent
• Received an HIV-positive test result
Inclusion criteria
• Aged 18 or older
• Unknown HIV status prior to visit
• Attending an EDARP HTC facility
• Willing and able to provide informed con-
sent
• Received an HIV-positive test result, or pre-
sumptive positive
Inclusion criteria
• FSW aged 18 or older
• Provides informed consent
• Received an HIV-positive test result
Exclusion criteria
• Indeterminate HIV result
• Not willing to enrol on follow-up at facility
• Taking pre-exposure prophylaxis
Exclusion criteria
• Indeterminate HIV result
• Prior history of testing HIV-positive
(>1 year ago)
• On ART
Specimen collection and testing
• Study nurse or laboratory phlebotomist
drew a maximum of 10ml of venous blood
• Samples packed and transferred to KEMRI-
Centre for Global Health Research HIV
Research Laboratory in Kisumu on a daily
basis where they were tested (or stored for
testing)
Specimen collection and testing
Study nurse drew 6mL of venous blood
collected in an ethylenediaminetetraacetic
(EDTA) tube and a pipette was used to
dispense venous blood on two WhatmanTM
903 Snap-Apart Cards with 5 dried blood
spots (DBS) of 70 µL each, for a total of 10
filled spots per participant
Specimen collection and testing
• Study nurse drew venous blood (where
study nurse not available, then a clinic nurse
drew blood)
• Samples packed and transferred to labora-
tory in Harare within 36 hours and stored
at 20C or below for testing
Inclusion and exclusion criteria for each pilot reflect the routine practice of the facilities within which recruitment was conducted. FSW, Female
Sex Workers; HDSS, Health and Demographic Surveillance System; HTC, HIV Testing and Counselling; EIA, Enzyme-linked Immunosorbent Assay.
Rice BD et al. Journal of the International AIDS Society 2020, 23(S3):e25513
http://onlinelibrary.wiley.com/doi/10.1002/jia2.25513/full | https://doi.org/10.1002/jia2.25513
11
not possible to apply logistic regression adjusting for
multiple variables.
Using the Nairobi HTC data, we describe the characteristics
of HIV-positive women and men with recent and long-standing
infection. We applied logistic regression to compare the char-
acteristics of those with recent infection with those with long-
standing infection (it was not possible to compare to persons
testing HIV-negative as these data were not available). To
account for facility clustering, a generalized estimated equa-
tion (GEE) model that includes age at diagnosis, gender, and
HIV testing history was applied. In Nairobi, participants con-
firmed to be HIV-positive, were counselled on index-testing
and asked to bring their sexual partners to the facility for HIV
and recent infection testing. We describe the characteristics
of these partners.
Due to small cell counts, and to avoid deductive disclosure,
testing facility was either anonymized or combined in our anal-
ysis. Percentages are presented as among persons for whom
information was available, confidence intervals are presented
at the 95% level, and Wald and likelihood-ratio tests were
applied for logistic regression. In Zimbabwe (only pilot for
which the necessary data were available), we assessed recent
infection clustering by sample collection date and testing facil-
ity. STATA15 (Stata Corp, College Station, TX) was used for
analyses.
2.3 | Ethical approval
Local approval was provided by KEMRI Scientific Ethics
Review Unit (SERU application 3589) and London School of
Hygiene & Tropical Medicine (LSHTM) (reference number
14458) for the pilot in Kisumu, by the ethical committee of
Medical Research Council of Zimbabwe for the Zimbabwe
pilot and by Kenyatta National Hospital-University of Nairobi
Ethical Review Board for the pilot in Nairobi. Ethical approval
was also obtained at the LSHTM for the Zimbabwe pilot (ref-
erence number 14542) and Nairobi pilot (reference number
14585).
3 | RESULTS
3.1 | Siaya County, Kenya: antenatal clinics
providing PMTCT services
Over the study period, 2409 eligible women presented at par-
ticipating antenatal clinics, of whom 2364 (98.1%) consented
to participate in the study (Figure 2). Of these women, 1806
(76.4%) were under 30 years of age, 1792 (75.8%) were mar-
ried and 1157 (48.9%) had experienced three or more preg-
nancies. In total, 444 (18.8%) women tested HIV-positive, of
whom 426 (95.6%) had a valid LAg and viral-load test (18
women did not consent to recency testing). Among these 426
women, 106 (24.9%) tested recent prior to viral-load being
considered, with 11 (2.6%) testing recent with a viral-
load> 1000 copies/mL.
Of the 11 women classified as recent based on their LAg
and viral-load tests, one was reclassified as long-standing
when clinical documentation of treatment was also considered
(recency misclassification of 9.1% (1/11)). For this woman
there was clinical documentation of her having initiated treat-
ment almost four years prior to their sample collection date
within the study. Of the remaining ten women, one initiated
treatment 78 days prior to her study sample draw date. As
her first known HIV-positive date was on the same date as
ART initiation, she remained classified as recent. Another
woman initiated ART three days prior to her study sample
draw, and again remained classified as recent. Of the remain-
ing eight women, four initiated treatment on the same day as
their study sample draw, three initiated within 16 days of
their sample draw, and one did not have documented date of
ART initiation. Exploration of the women’s HIV testing history
for prevalent infection from the HDSS and ANC record, pro-
vided no further evidence of misclassification. In total 2.3%
(10/426) of women were classified recent.
A total of 10 women classified as recent were identified at
seven of the 14 clinics and had sample collection dates evenly
distributed across the study period. Nine (90%) of the 10
women were under 30 years of age, and half (55.6%; 5/9 (1
missing record)) were in their first trimester of pregnancy.
Comparing HIV-positive women testing recent with women
testing HIV-negative found women in their first trimester to
have nearly a ten times increased odds of testing recent com-
pared to those in their second or third trimester (Table 2).
There were no notable differences in age, marital status, study
facility, or number of pregnancies between HIV-negative
women and HIV-positive women testing recent.
Figure 2. Recruitment and testing flowchart for the three pilots.
*Eligibility criteria: providing consent for HIV testing & in Zimbabwe:
not having been tested in previous three months or taking ART.
**1914 tested HIV-negative, six had unknown HIV status. ***883
tested HIV-positive, but 255 of these tested HIV+ before. ****In
Siaya County, ART status was determined using clinic records; in Nair-
obi, ART status was determined using ARV metabolite testing; in Zim-
babwe, ART status was not determined. RITA, recency testing
algorithm
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3.2 | Zimbabwe: national programme for female sex
workers
In Zimbabwe, 9138 women presented at one of the six partic-
ipating facilities, of whom 4349 (47.6%) were tested for HIV
(routinely, women who have tested for HIV within the past
three months, or who report ART use, are not offered an HIV
test). Of these 4349 women, 511 (11.7%) tested HIV-positive,
and of these, 313 (61.3%) agreed to have a sample taken for
viral-load and recent infection testing. Almost half (141;
46.7%) of these women were aged between 25 and 34 years,
and the majority attained a secondary school education (247;
81.8%) and/or were separated or divorced (177; 58.6%).
Among the 313 women who tested HIV positive, and for
whom both a viral-load and a recent infection test was avail-
able, 15.7% (49/313) tested recent based on their LAg test
result alone. Based on their LAg and viral-load (>1000 copies/
mL), 33 (10.5%) of these women were classified as recent
(Figure 2). Among the 313 women testing HIV-positive, by
age, those aged 18 or 19 years had the highest percentage of
recent infection (5/23; 21.7%). By education, HIV-positive
women for whom secondary education was their highest
attainment were most likely to test recent (31/246; 12.6%),
whereas by marital status, those who were single or never
married presented with the highest percentage of recent
infection (17/87; 19.5%).
Table 3 characterizes HIV positivity among the 4349
women tested for HIV, and also presents a risk factor analysis
of recent infection, comparing HIV-positive women with
recent infection to HIV-negative women, adjusting for age and
study facility. There was no strong evidence of an association
between having a recent infection and any of the variables.
A visual assessment of the data suggested some clustering
by sample collection date and testing facility. On one day dur-
ing week five of recruitment, six women tested positive for
recent infection. Three of these women tested at the same
facility, and three were aged between 20 and 24 years. A sta-
tistical analysis of clustering over time (logistic regression with
sample collection date as covariate) found no evidence of an
association between recency test results and week (p = 0.74)
or month (p = 0.21).
3.3 | Nairobi, Kenya: routine HIV testing and
counselling clinics
In Nairobi, 50,561 eligible women and men presented at one
of the fourteen participating facilities. Of these, 883 (1.75%)
tested HIV-positive, of whom 255 (28.9%) were subsequently
found on enquiry (self-reported test history) to have tested
HIV-positive before and were therefore ineligible for recency
testing (Figure 2). In total, 532 (84.7%; 628) of those eligible
consented to test for recent infection. Among these, 316
(59.4%) were female, of whom 57 (18%) were pregnant. The
majority of participants (64.1%; 341) had previously tested for
HIV, with a third (33.6%; 179) having tested in the past
12 months.
Two of the 532 people consenting to participate were sub-
sequently found to have insufficient sample to test. Of the
remaining 530 people testing for recent infection and viral-
load, 60 (11.3%) tested recent based on the LAg test result
Table 2. Characterization of HIV and recent infection among antenatal clinic attendees in Siaya County testing for HIV
Characteristics
HIV positivity Risk factor analysis for recent infection
n/Na (%) n/Nb (%) Crude OR (95% CI) p-value
Age (years)
<20 30/503 (6.0) 2/475 (0.4) 0.74 (0.10 to 3.8) 0.72
20 to 24 100/794 (12.6) 4/698 (0.6) 1 -
25+ 314/1060 (29.6) 4/750 (0.5) 0.93 (0.22 to 3.9) 0.92
Study site
1c 102/522 (19.5) 3/423 (0.7) 1.5 (0.33 to 5.5) 0.54
Other 342/1836 (18.6) 7/1501 (0.5) 1
Marital status
Married 364/1787 (20.4) 7/1430 (0.5) 1
Single 40/500 (8.0) 2/462 (0.4) 0.88 (0.13 to 3.7) 0.88
Separated/ divorced/ widowed 39/69 (56.5) 1/31 (3.2) 6.8 (0.36 to 39.8) 0.08
Trimester
1st 74/289 (25.6) 5/215 (2.3) 9.6 (2.5 to 39.2) <0.001
2nd & 3rd 347/2005 (17.3) 4/1658 (0.2) 1 -
Pregnancies
1 39/663 (5.9) 3/627 (0.5) 1
2 91/519 (17.5) 5/433 (1.2) 2.4 (0.59 to 11.9) 0.22
3+ 302/1157 (26.1) 2/857 (0.2) 0.49 (0.06 to 2.9) 0.43
an = testing HIV-positive; N = testing for HIV; bn = testing recent; N = testing HIV-negative + testing recent; cTesting facility 1is the largest facil-
ity by patient volume.
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alone, with 48 (9.1%) testing recent with a viral-load> 1000
copies/ml (Table 4). ART metabolite testing identified one
woman and one man among these 48 to have been wrongly
classified (misclassification of 4.2%). In total, 8.7% (46/530) of
people were classified as recent. Among women this percent-
age was 12.4% (39/315) and among men 3.3% (7/215).
Around half (45.7%; n = 21) of the 46 people newly testing
HIV-positive who also tested recent were aged under
25 years and the proportion with a recent infection declined
with increasing age, see Table 4. Just over half of those test-
ing recent were married or co-habiting (52.2%; n = 24), and
had tested HIV-negative in the past 12 months (54.3%;
n = 25). The percentage of people newly testing HIV-positive
who had previously tested for HIV during the past 12 months
was higher among those classified as recent (54.3%; n = 25)
than among those classified as having long-standing infection
(31.6%; 153/484).
Among people newly testing HIV-positive (recent and long-
standing infection), being a woman, being under 25 years of
age, having tested for HIV in the last 12 months, and presenting
at the facility with the largest catchment area and largest corre-
sponding patient volume were shown to be individually predic-
tive of recent infection (Table 4). Testing for interactions
indicated an interaction between age at diagnosis and gender
(Table 5). Young women (15 to 29 years old) had 3.85 times the
odds of recent infection than men in the same age group. Partic-
ipants reporting having tested for HIV in the past 12 months
had 1.72 times the odds of recent infection compared to those
reporting having last tested more than 12 months ago.
Following an HIV-positive test result and counselling, 144
(27.1%) of participants subsequently brought a sexual partner
to the clinic for HIV testing. Of these 144, two brought in
two partners, making the total 146. Among the 146 sexual
partners of index cases testing for HIV, 61 (41.8%) tested
positive for HIV. Among these 61 HIV-positive partners, 21
subsequently enrolled in the pilot, of whom five (5/21; 23.8%)
were classified as recent. The percentage of partners testing
HIV-positive, and being classified as recent, were significantly
higher than the corresponding percentages among all non-
partner (i.e. the recruitment figures presented above less the
146 partners) participants (p < 0.001 & p = 0.019 respec-
tively).
4 | DISCUSSION
We successfully conducted three independent but linked pilots
in routine programme setting in Kenya and Zimbabwe to iden-
tify people with recently acquired HIV infection. Among HIV-
positive participants, we report 2.3% of pregnant women in
Siaya County, 10.5% of FSW in Zimbabwe and 12.4% of
women and 3.3% of men attending HTC facilities in Nairobi to
have been diagnosed with recent infection. Among partners of
participants in Nairobi, the percentage was 23.8%.
In Siaya County we found women in their first trimester to
be significantly more likely to test recent compared to those
in their second or third trimester. While inference with small
numbers is challenging, this finding may relate to increased
Table 3. Characterization of HIV and recent infection among female sex workers testing for HIV in Zimbabwe
HIV positivity Risk factor analysis for recent infection
n/Na (%) n/Nb (%) Crude OR (95% CI) p-value Adjusted ORc (95% CI) p-value
Age (years) 0.37 0.3
18 to 19 39/405 (9.6) 5/372 (1.4) 1 1
20 to 24 143/1309 (10.9) 13/1180 (1.1) 0.82 (0.29 to 2.31) 0.79 (0.28 to 2.25)
25 to 34 232/1679 (13.8) 13/1460 (0.9) 0.66 (0.23 to 1.86) 0.60 (0.21 to 1.74)
35+ 78/676 (11.5) 2/600 (0.3) 0.24 (0.05 to 1.27) 0.22 (0.04 to 1.16)
Study site 0.18 0.12
1 89/744 (12.0) 6/661 (0.9) 1 1
2 57/414 (13.8) 1/358 (0.3) 0.31 (0.04 to 2.55) 0.33 (0.04 to 2.79)
3 228/1518 (15.0) 11/1302 (0.9) 0.93 (0.34 to 2.53) 1.04 (0.38 to 2.87)
4 37/357 (10.4) 5/325 (1.5) 1.71 (0.52 to 5.63) 2.08 (0.62 to 6.94)
5 61/477 (12.8) 7/423 (1.7) 1.84 (0.61 to 5.50) 2.08 (0.69 to 6.28)
6 39/839 (4.7) 3/803 (0.4) 0.41 (0.10 to 1.64) 0.42 (0.10 to 1.69)
Education 0.15 0.15
Primary or less 87/635 (13.7) 2/550 (0.4) 1 1
Secondary or higher 400/3374 (11.9) 31/3005 (1.0) 2.87 (0.68 to 12.01) 2.89 (0.68 to 12.24)
Marital status 0.12 0.07
Single/ never married 148/1341 (11.0) 17/1210 (1.4) 1 1
Married/ living together as if married 30/149 (20.1) 2/121 (1.7) 1.18 (0.27 to 5.17) 1.82 (0.39 to 8.45)
Divorced/ separated 290/2372 (12.2) 13/2098 (0.6) 0.44 (0.21 to 0.90) 0.38 (0.17 to 0.84)
Widowed 24/188 (12.8) 1/165 (0.6) 0.43 (0.06 to 3.24) 0.50 (0.06 to 4.18)
an = testing HIV-positive (of the 511 women testing HIV positive, regardless of viral-load and recency test); N = testing for HIV; bn = testing
recent; N = testing HIV-negative + testing recent; cAdjusted for age and study site. OR, odds ratio; CI, confidence interval.
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risk of HIV infection during unprotected sex leading to preg-
nancy, and/or may be due to lowered coital frequency among
women later in pregnancy. The former of these two potential
explanations would support the targeting of women trying to
get pregnant, particularly those in sero-discordant couples,
with interventions such as PrEP and partner testing. In Kenya,
the offering of HTC to the partners of persons diagnosed with
HIV is already encouraged [19].
Among FSW in Zimbabwe, there was no strong evidence of
associations with testing recent when comparing HIV-positive
women with recent infection to HIV-negative women. One
likely reason for this is the relatively small number of women
found to have a recent infection. Despite a lack of association,
and despite FSW in Zimbabwe being a known high-risk group
[20,21], we would argue that ongoing efforts to differentiate
prevention needs among FSW are applicable. These efforts
should include the expanded roll-out of recency testing at
venues utilized by FSW and, where possible, through the col-
lection of more detailed information on previous HIV test his-
tory.
In Nairobi, we found young women newly testing HIV-posi-
tive were significantly more likely to test recent than their
male counterparts. The observed difference by sex is probably
due to women presenting earlier in their course of infection
than men. Among those newly testing HIV-positive, women, as
compared to men, were younger at age of HIV diagnosis, and
were more likely to have ever tested and to have tested
within the last 12 months. We were unable to investigate why
women may present earlier than men. We also found partici-
pants newly testing HIV-positive who had tested for HIV in
the past 12 months were significantly more likely to test
recent than those having tested over a year ago. This probably
reflects that people who are HIV-negative that test more fre-
quently (potentially due to engaging more frequently in risk
behaviour) will test recent when first diagnosed with HIV.
Interestingly, we found significantly higher yields of HIV and
recent infection among partner, as compared to non-partner,
participants in Nairobi. Although based on small numbers,
these results provide support for recency test results among
index cases informing partner testing strategies [15].
In two of our three pilots there was some suggestion of
clustering by sample collection date or testing facility. In Zim-
babwe, six of the 33 women testing recent did so on the same
day, with three also testing at the same facility. In Nairobi, the
facility with the largest catchment area and patient volume
presented with a significantly higher percentage of recent
infections than at smaller facilities. Although we only present
suggestive evidence, information on recent infection clustering
in time and space could be used to target prevention efforts
in specific geographical areas and specific populations; for
example mobilizing outreach teams to promote HIV testing or
deliver PrEP.
Several studies have explored recent infection testing in sub-
Saharan Africa. A number of these studies conducted recency
testing as a means to estimate HIV incidence rather than an
end in itself [22,23]. However, a couple of studies provide
details on recency testing and present recency percentages
similar to those we report. Among participants aged 15 to
49 years providing DBS samples as part of the 2012 national
population-based household surveys in Kenya and South Africa,
4.5% (21/470) and 3.3% (73/2,202) tested recent respectively
[4]. The authors of this study conclude that information on
viral-load and ART-exposure in their RITA potentially improved
the predictive value of the RITA [4]. Another study tested the
Table 4. Characterization of recent and long-standing infection
among women and men newly testing HIV-positive in HIV test-
ing and counselling facilities in Nairobi
Characteristicsa Recent Long-standing
Recencyb
N = 530 N = 46 % N = 484 % %
Sex
Male 7 15.2 208 43.0 3.3
Female 39 84.8 276 57.0 12.4
Age (years)
15 to 19 5 10.9 13 2.7 27.8
20 to 24 16 34.8 79 16.3 16.8
25 to 29 13 28.3 102 21.1 11.3
30 to 34 7 15.2 100 20.7 6.5
35 to 39 2 4.3 80 16.5 2.4
40+ 3 6.5 110 22.7 2.7
Testing facility
1c 9 19.6 36 7.5 20.0
Other 37 80.4 447 92.5 7.6
Marital status
Single 15 32.6 97 20.0 13.4
Married/co-habiting 24 52.2 269 55.6 8.2
Separated 6 13.0 74 15.3 7.5
Divorced 0 0.0 10 2.1 0.0
Widowed 1 2.2 31 6.4 3.1
Unknown 0 0.0 3 0.6 0.0
Highest level of education
None 2 4.3 7 1.4 22.2
Primary 16 34.8 251 51.9 6.0
Secondary 21 45.7 176 36.4 10.7
Tertiary 7 15.2 48 9.9 12.7
Unknown 0 0.0 2 0.4 0.0
Employment status
Employed 28 60.9 347 71.7 7.5
Unemployed 18 39.1 135 27.9 11.8
Unknown 0 0.0 2 0.4 0.0
Ever tested for HIV
Yes 35 76.1 305 63.0 10.3
No 11 23.9 179 37.0 5.8
Tested for HIV in last 12 months
Yes 25 54.3 153 31.6 14.0
No 21 45.7 329 68.0 6.0
Unknown 0 0.0 2 0.4 0.0
Pregnancy status (n = 316)
Pregnant 10 25.6 47 17.0 17.5
Not-pregnant 29 74.4 229 83.0 11.2
aExcludes two participants for whom there was insufficient sample to
test; bCalculated as recent infection/ newly testing HIV-positive (re-
cent & long-standing infections); the denominator only includes new
HIV-positives as repeat testers were excluded; cTesting facility 1 is
the largest facility by catchment area and patient volume
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DBS stored samples of people aged 15 to 64 years participat-
ing in the 2007 Kenya AIDS Indicator Survey for recent infec-
tion. Among these participants, 6.2% (64/1,025) were classified
as recent [3]. Compared to persons testing HIV-negative, fac-
tors associated with recent infection in this population included
being widowed or currently married (compared to being never
married), having had two or more sexual partners in the last
year, not using a condom at last sex in the past year, and
reporting a sexually transmitted infection diagnosis or symp-
toms in the past year [3].
There were a number of limitations to our study. In Siaya
county and Zimbabwe recency testing was conducted on
venous blood samples whereas in Nairobi DBS was used. As
we did not compare the performance of these two methods,
results across the three pilots should be compared with cau-
tion. We planned to conduct ART metabolite testing in all
three pilots. Due to challenges in attaining import and export
licences to transport samples to the University of Cape Town
we were only successful in carrying out ART testing in our
Nairobi pilot. In Zimbabwe, routinely applied criteria for con-
ducting an HIV test reduced the number of women eligible
for inclusion in our study, thereby potentially reducing the
number of women found to be HIV-positive and recent. Fur-
thermore, the fairly low participation rate in recency testing
(61.3%) among the women testing HIV-positive ensures our
results should be interpreted with caution, given the possibil-
ity for selection bias. In Nairobi, we were unable to attain
detailed information on people testing HIV-negative. There-
fore, in contrast to Siaya County and Zimbabwe, we compare
persons testing recent with long-standing infection rather than
HIV-negativity.
For programmes to include recency testing as part of rou-
tine HIV service delivery for the purpose of identifying prior-
ity populations for primary prevention efforts (the first step of
a unifying HIV prevention cascade framework described by
Schaefer et al) [24], there are a number of considerations.
Programmes can anticipate additional costs resulting from test
assays and logistics related to sample handling [25], needing
to make modifications to client flows (e.g. to draw additional
amounts of blood for laboratory-based testing), and providing
additional training to healthcare workers. The collection, trans-
portation, storage and testing of samples (DBS and plasma)
will need to be closely monitored to ensure assay manufac-
turer’s instructions for use are being followed, and testing lab-
oratories will require training in the performance of the assay
and should partake in an external quality-assurance scheme.
To guarantee the inclusion of ART metabolite testing in the
interpretation of LAg test results, the process for transporting
samples outside of country should be reviewed prior to com-
mencement of testing, and simpler assays should be devel-
oped so that blood samples may be tested at in-country
laboratory facilities. Finally, programmes will need to consider
potential prevention interventions resulting from recent infec-
tions, such as partner testing, PrEP delivery and community
prevention initiatives.
5 | CONCLUSIONS
At a time when the national surveillance of recent infection is
being promoted across sub-Saharan Africa [14,15], we show
that integrating recency testing into routine programme activi-
ties in Kenya and Zimbabwe is feasible. In identifying recently
acquired infections among persons testing HIV-positive, we
highlight the importance of incorporating information on viral-
loads and ART to accurately classify recent infection. Having
identified a number of groups with a significantly higher pro-
portion of recent infection, we highlight how recency surveil-
lance may help us in further targeting primary prevention
efforts. The identification of hotspots of transmission and
characteristics associated with new infection, even among
high-incidence populations, could inform where and among
whom primary prevention efforts should be strengthened.
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Table 5. Predictors of recent infection, disaggregated by gender, among women and men newly testing HIV-positive in HIV testing
and counselling facilities in Nairobi
Male Female
N aOR (95%CI) p-value N aOR (95%CI) p-value
Aged 15 to 29 years 58 1 - 171 1 -
Aged 30+ years 158 0.99 [0.94, 1.06] 0.87 145 0.23 [0.16, 0.32] <0.01
Tested over 12 months ago 162 1 - 189 1 -
Tested within last 12 months 53 1.05 [1.01, 1.08] 0.01 126 2.12 [1.83, 2.45] <0.01
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